A method for preparing carbaspirin calcium

By using calcium oxide or calcium hydroxide in methanol, ethanol or isopropanol solvents to react with aspirin and urea, the safety hazards, high costs and many by-products of the existing cabapirin calcium preparation process are solved, and high efficiency is achieved , environmentally friendly and economical preparation of cabapirin calcium, suitable for industrial production.

CN115572227BActive Publication Date: 2024-11-15山东中科绿碳科技有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211261300.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-14
Publication Date
2024-11-15
Estimated Expiration
2042-10-14

AI Technical Summary

Technical Problem

The existing cabapilin calcium preparation process has problems such as safety hazards, high production costs, many by-products, and unfavorable to industrial production.

Method used

Calcium oxide or calcium hydroxide as calcium source and acid binding agent, by reacting with aspirin and urea in methanol, ethanol or isopropanol solvents, the reaction temperature and time are controlled, and the efficient preparation of cabapilin calcium is achieved, and only the product is produced. and water, simplify process flow and reduce costs.

Benefits of technology

It has achieved high purity and high yield preparation of cabapiline calcium, which is safe, environmentally friendly and economical, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure QLYQS_1
    Figure QLYQS_1
  • Figure BDA0003891145270000021
    Figure BDA0003891145270000021
  • Figure BDA0003891145270000031
    Figure BDA0003891145270000031
Patent Text Reader

Abstract

The invention relates to a method for preparing carbaspirin calcium by using alcohol as a solvent, aspirin and urea as raw materials, and calcium oxide or calcium hydroxide as both a calcium source and an acid-binding agent. The method is safe and environmentally friendly, has a simple process, and has good guiding significance for realizing industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of pharmaceutical chemistry, in particular to a preparation method of an antipyretic and analgesic drug, specifically a preparation method of veterinary drug carbaspirin calcium. Background Art

[0002] Calcium carbaspirin, also known as calcium acetylsalicylate urea or calcium aspirin urea, is a complex of calcium acetylsalicylate and urea, and its chemical name is bis-(calcium 2-acetoxybenzoate) urea. Calcium carbaspirin has good water solubility and rapid oral absorption, and has antipyretic, analgesic and anti-inflammatory effects. Calcium carbaspirin has been included in the European Pharmacopoeia, is listed as an over-the-counter drug in the United States, and is a Class III new drug in China. It is the only antipyretic and analgesic approved by the Ministry of Agriculture of my country for use in edible animals such as pigs, chickens, and cattle. Calcium carbaspirin can be used in drinking water and mixed with feed, has no residue in the animal body, does not require a drug withdrawal period, and has broad market prospects.

[0003] In the prior art CN 101575305A, methanol or ethanol is used as a single solvent, aspirin, calcium nitrate, urea, etc. are stirred and dissolved, and then an alcohol ammonia solution is introduced for crystallization to the end point of the reaction, centrifuged, and dried, with a yield of 95-96%. Although this method overcomes the problems of poor safety, high cost, and difficulty in solvent recovery caused by the use of a mixed solvent of ethylene glycol monomethyl ether and ethanol, it still cannot avoid the generation of a large amount of by-product ammonium nitrate, and ammonium nitrate is an explosive product, so there is a great safety hazard when treating the generated waste liquid.

[0004] In the prior art CN 114315574A, ethanol / water is used as solvent, aspirin, calcium chloride and urea are stirred and dissolved, triethylamine is added dropwise with a DSC system to control the temperature, and after the reaction is completed, the temperature is lowered for crystallization, suction filtration is performed, the filter cake is rinsed with ethanol, and dried to obtain carbaspirin calcium with a yield of about 94%. The filtrate of this method is concentrated and recovered for ethanol reuse, which reduces the use of solvents and production costs, but still produces more triethylamine hydrochloride waste residues. Other reports have used similar processes to use ammonia or ammonia water as a synthetic method for acid binding agents, but ammonium chloride waste liquid or waste residues will still be produced in the end.

[0005] In the prior art CN 102382013A, water is used as a solvent, aspirin and urea are added and stirred, and then calcium carbonate is added in batches, and stirring is continued for a period of time after the addition is completed, and insoluble matter is removed by filtration, methanol is added to the filtrate for crystallization, and the filter cake is soaked and washed with methanol, filtered, and dried, and the product yield can reach 94%. This method uses calcium carbonate as a calcium source and an acid binding agent, reduces costs, and does not produce inorganic salt waste residue, but produces carbon dioxide gas, which is not conducive to industrial production.

[0006] In the prior art CN 106496074A, aspirin and urea are first added to water and stirred to dissolve, and then added dropwise to a calcium hydroxide / water suspension, filtered after the reaction, and the filtrate is spray-dried to obtain the product with a yield of about 95%. This method uses calcium hydroxide as both a calcium source and an acid-binding agent, which is safe and environmentally friendly, but the spray drying equipment is expensive, resulting in huge initial investment in production.

[0007] Therefore, improving the existing preparation process of carbaspirin calcium has important practical value. Summary of the invention

[0008] Problem that the invention aims to solve

[0009] In order to solve the above problems existing in the prior art, the present invention provides a method for preparing carbaspirin calcium which is simple to operate, economical, friendly to reaction equipment and suitable for industrial production.

[0010] Solutions for solving problems

[0011] The present invention provides a method for preparing carbaspirin calcium, the method comprising the following steps:

[0012]

[0013] Step S: aspirin, a calcium source and urea react in solvent 1 to obtain carbaspirin calcium;

[0014] The calcium source is selected from one or more of calcium oxide and calcium hydroxide;

[0015] The solvent 1 is selected from one or more of methanol, ethanol and isopropanol.

[0016] Preferably, the mass ratio of aspirin to urea in step S is 1:0.1-1, preferably 1:0.2-0.3.

[0017] Preferably, in step S, the mass ratio of aspirin to calcium oxide is 1:0.1-0.3, preferably 1:0.15-0.2.

[0018] Preferably, in step S, the mass ratio of aspirin to calcium hydroxide is 1:0.2-0.4, preferably 1:0.24-0.3.

[0019] Preferably, in step S, the mass volume ratio of aspirin to solvent 1 is 1:2-20, preferably 1:6-7; the unit is g / mL.

[0020] Preferably, the reaction temperature of step S is 0-50°C, preferably 20-40°C.

[0021] Preferably, the reaction time of step S is 1-10 hours, preferably 4-5 hours.

[0022] Preferably, the post-processing step of step S comprises: after the reaction is completed, filtering, and drying the filter cake to obtain the product.

[0023] Effects of the Invention

[0024] The invention uses calcium oxide or calcium hydroxide as both a calcium source and an acid-binding agent to synthesize carbaspirin calcium, only generates products and water, is safe and environmentally friendly, has a simple process, low cost, good economic benefits, and has good guiding significance for realizing industrial production. At the same time, the preparation method of the invention has a high reaction yield, the obtained product has high purity, and is suitable for industrial production. DETAILED DESCRIPTION

[0025] In order to make the technical solutions and beneficial effects of the present invention more clearly understood, the following is a detailed description by listing specific embodiments. Unless otherwise defined, the technical and scientific terms used herein have the same meanings as those in the technical field to which this application belongs.

[0026] The present invention provides a method for preparing carbaspirin calcium, the method comprising the following steps:

[0027]

[0028] Step S: aspirin, a calcium source and urea react in solvent 1 to obtain carbaspirin calcium;

[0029] The calcium source is selected from one or more of calcium oxide and calcium hydroxide;

[0030] The solvent 1 is selected from one or more of methanol, ethanol and isopropanol.

[0031] In certain embodiments, the mass ratio of aspirin to urea in step S is 1:0.1-1.

[0032] In certain embodiments, the mass ratio of aspirin to urea in step S is 1:0.2-0.3.

[0033] In certain embodiments, the mass ratio of aspirin to urea in step S is 1:0.20, 1:0.21, 1:0.22, 1:0.23, 1:0.24, 1:0.25, 1:0.26, 1:0.27, 1:0.28, 1:0.29, or 1:0.30.

[0034] In certain embodiments, the mass ratio of aspirin to calcium oxide in step S is 1:0.1-0.3.

[0035] In certain embodiments, the mass ratio of aspirin to calcium oxide in step S is 1:0.15-0.2.

[0036] In certain embodiments, the mass ratio of aspirin to calcium oxide in step S is 1:0.15, 1:0.16, 1:0.17, 1:0.18, 1:0.19, or 1:0.20.

[0037] In certain embodiments, the mass ratio of aspirin to calcium hydroxide in step S is 1:0.2-0.4.

[0038] In certain embodiments, the mass ratio of aspirin to calcium hydroxide in step S is 1:0.24-0.3.

[0039] In certain embodiments, the mass ratio of aspirin to calcium hydroxide in step S is 1:0.24, 1:0.25, 1:0.26, 1:0.27, 1:0.28, 1:0.29, or 1:0.30.

[0040] In certain embodiments, the mass volume ratio of aspirin to solvent 1 in step S is 1:2-20, expressed in g / mL.

[0041] In certain embodiments, the mass volume ratio of aspirin to solvent 1 in step S is 1:6-7, expressed in g / mL.

[0042] In certain embodiments, the mass volume ratio of aspirin to solvent 1 in step S is 1:6.0, 1:6.1, 1:6.2, 1:6.3, 1:6.4, 1:6.5, 1:6.6, 1:6.7, 1:6.8, 1:6.9, or 1:7.0.

[0043] In certain embodiments, the reaction temperature of step S is 0-50°C.

[0044] In certain embodiments, the reaction temperature of step S is 20-40°C.

[0045] In certain embodiments, the reaction temperature of step S is 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, or 40°C.

[0046] In certain embodiments, the reaction time of step S is 1-10 hours.

[0047] In certain embodiments, the reaction time of step S is 4-5 hours.

[0048] In certain embodiments, the reaction time of step S is 4.0 hours, 4.5 hours, or 5.0 hours.

[0049] In certain embodiments, the reaction is carried out in batch addition or dropwise addition.

[0050] In certain embodiments, the order of addition may be selected such that the aspirin solid is added in batches to the suspension of the calcium source and urea.

[0051] In certain embodiments, the addition sequence may be to add the aspirin alcohol solution dropwise to the suspension of the calcium source and urea.

[0052] In certain embodiments, the order of addition may be selected such that the calcium source is added to the aspirin and urea solution in batches.

[0053] In certain embodiments, the order of addition may be to add the calcium source suspension dropwise to the aspirin and urea solution.

[0054] In certain embodiments, the post-processing step of step S comprises: after the reaction is completed, filtering, and drying the filter cake to obtain the product.

[0055] The method of the present invention is described below by means of specific examples. It should be understood that these examples are used to illustrate the basic principles, main features and advantages of the present invention, and the present invention is not limited to the scope of the following examples; the implementation conditions adopted in the examples can be further adjusted according to specific requirements, and the implementation conditions not specified are usually the conditions in routine experiments.

[0056] In the following examples, unless otherwise specified, all temperatures are in degrees Celsius. Unless otherwise specified, various starting materials and reagents are commercially available or synthesized according to known methods. Commercially available materials and reagents are used directly without further purification. Unless otherwise specified, commercial manufacturers include but are not limited to Sinopharm Group, J&K Technology Co., Ltd., TCI (Shanghai) Chemical Industry Development Co., Ltd., Shanghai Bid Pharmaceutical Technology Co., Ltd. and Shanghai Myrel Chemical Technology Co., Ltd.

[0057] Unless otherwise specified in the examples, the solution in the reaction refers to an aqueous solution.

[0058] Unless otherwise specified in the examples, the reaction temperature is room temperature, 20°C to 30°C.

[0059] Example 1

[0060] Add 310 ml of methanol, 8.6 g of calcium oxide and 13 g of urea into a 500 ml three-necked flask and stir mechanically for 5 minutes. Add 50 g of solid aspirin in 4-5 batches over about 1 hour. Then control the temperature to 30-40 ° C and react for 5 hours. Filter with suction and dry the filter cake to obtain 60.2 g of white powder, with a yield of 94.6% and a content of 98%.

[0061] Example 2

[0062] Weigh 50g of aspirin in a 500ml beaker, add 150ml of methanol, stir and dissolve, and set aside; add 150ml of methanol, 8.5g of calcium oxide and 8.5g of urea to a 500ml three-necked flask, stir mechanically, then dropwise add the above aspirin methanol solution, add it in about 1 hour, then control the temperature at 20-30℃ to react for 4 hours; filter with suction, dry the filter cake, and obtain 59.3g of white powder, with a yield of 93.2% and a content of 98.2%.

[0063] Example 3

[0064] Add 320 ml of methanol, 12.9 g of calcium hydroxide and 12 g of urea into a 500 ml three-necked flask, stir mechanically for 5 minutes, add 50 g of solid aspirin in 4-5 batches, add it all in about 1 hour, control the temperature at 22-31 ° C and react for 5 hours; filter with suction, dry the filter cake, and obtain 60.7 g of white powder, yield: 95.4%, content: 99%.

[0065] Example 4

[0066] Weigh 50g of aspirin in a 500ml beaker, add 150ml of methanol, stir and dissolve, and set aside; add 150ml of methanol, 13.2g of calcium hydroxide and 15g of urea to a 500ml three-necked flask, stir mechanically for 5 minutes, then dropwise add the above aspirin methanol solution, add it all in about 1 hour, then control the temperature at 20-30℃ to react for 4.5 hours; filter with suction, dry the filter cake, and obtain 61.1g of white powder, with a yield of 96% and a content of 98.3%.

[0067] Example 5

[0068] Add 350ml of methanol, 50g of aspirin and 15g of urea into a 500ml three-necked flask, stir mechanically to dissolve, add 12.4g of solid calcium hydroxide in 5-6 batches, add it in about 1 hour, then control the temperature at 20-30℃ to react for 5 hours; filter with suction, dry the filter cake to obtain 60g of white powder, yield: 94.3%, content: 99.1%.

[0069] Example 6

[0070] Add 200 ml of methanol, 50 g of aspirin and 15 g of urea into a 500 ml three-necked flask, stir mechanically to dissolve, add dropwise a methanol suspension of calcium hydroxide (12.5 g / 100 ml), add the mixture in about 1 hour, then control the temperature at 23-32 ° C to react for 5 hours; filter with suction, dry the filter cake to obtain 59.4 g of white powder, with a yield of 93.3% and a content of 99.6%.

[0071] It should be understood that the above embodiments are exemplary and are not intended to include all possible implementations included in the claims. Various modifications and changes may be made on the basis of the above embodiments without departing from the scope of the present disclosure. Similarly, the various technical features of the above embodiments may be arbitrarily combined to form other embodiments of the present invention that may not be explicitly described. Therefore, the above embodiments only express several implementations of the present invention and do not limit the scope of protection of the patent of the present invention.

Claims

1. A method for preparing carbaspirin calcium, characterized in that: The method comprises the following steps: ; Step S: aspirin, a calcium source and urea react in solvent 1 to obtain carbaspirin calcium; The calcium source is selected from calcium oxide; The solvent 1 is selected from one or more of methanol, ethanol and isopropanol; The reaction temperature of step S is 20-40°C; The post-processing step of step S comprises: after the reaction is completed, filtering, and drying the filter cake to obtain the product; In the step S, the mass ratio of aspirin to urea is 1:0.1-1; In the step S, the mass ratio of aspirin to calcium oxide is 1:0.1-0.3; In the step S, the mass volume ratio of aspirin to solvent 1 is 1:2-20; the unit is g / mL.

2. The method according to claim 1, characterized in that In the step S, the mass ratio of aspirin to urea is 1:0.2-0.

3.

3. The method according to any one of claims 1 to 2, characterized in that: In the step S, the mass ratio of aspirin to calcium oxide is 1:0.15-0.

2.

4. The method according to any one of claims 1 to 2, characterized in that: The mass volume ratio of aspirin to solvent 1 in step S is 1:6-7; the unit is g / mL.

5. The method according to any one of claims 1 to 2, characterized in that: The reaction time of step S is 1-10 hours.

6. The method according to claim 5, characterized in that The reaction time of step S is 4-5 hours.